Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.67 USD | +10.41% | +11.78% | +34.76% |
05-24 | JPMorgan Adjusts Price Target on Cellebrite DI to $14 From $12, Maintains Overweight Rating | MT |
05-24 | Deutsche Bank Adjusts Price Target on Cellebrite to $15 From $13, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.76% | 2.4B | |
+13.78% | 3,180B | |
+11.90% | 88.28B | |
+8.74% | 81.2B | |
-16.88% | 51.97B | |
+34.71% | 51.51B | |
+28.75% | 45.32B | |
-31.82% | 42.21B | |
+80.17% | 41.91B | |
-0.25% | 27.51B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Earnings Flash (CLBT) CELLEBRITE DI Reports Q2 Revenue $76.7M, vs. Street Est of $72.5M